Less may be more: smaller dose of pain drug could be safer after gallbladder surgery
NCT ID NCT07507799
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares a low volume of the painkiller bupivacaine to the standard volume for a nerve block after gallbladder surgery. The goal is to see if the lower dose controls pain just as well while reducing the risk of side effects. About 96 adults having planned gallbladder surgery will take part.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- bupivacaine
- What this could lead to
- If it works, this could lead to safer pain control after gallbladder surgery with less risk of side effects from the anesthetic.
- What could go wrong
- This is a small, early-stage trial with only 96 participants, so results may not apply to everyone. The lower volume might not control pain as well as the standard dose.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN, POSTOPERATIVE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fayoum University hospital
El Fayoum Qesm, Faiyum Governorate, 63514, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a single nerve block slash opioid use in Children's elbow surgery?
- Can a simple pill speed up knee replacement recovery?
- A pinprick test may forecast severe pain after C-Section
- Smartphone video may read pain in a Patient's face
- Which nerve drug wins the battle against Post-Surgical knee pain?
- Could a VR headset replace pills for surgery anxiety?